Carregant...
Cardiotoxicity of concomitant radiotherapy and trastuzumab for early breast cancer
BACKGROUND: Trastuzumab therapy given in combination with one of several chemotherapy regimens is currently considered the standard of care for the treatment of early-stage, human epidermal growth factor receptor-2 (HER2) -positive breast cancer. The treatment with trastuzumab is due to a significan...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Versita, Warsaw
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4078028/ https://ncbi.nlm.nih.gov/pubmed/24991199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/raon-2013-0040 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|